Gauge Fund IV Oversubscribed at $1.4 Billion

Carolyn Mains 5/16/22 Carolyn Mains 5/16/22

Elsewhere Partners II, L.P. Closed at $175 Million

Carolyn Mains 2/23/22 Carolyn Mains 2/23/22

Morpheus Ventures II Oversubscribed at $200 Million

Carolyn Mains 12/31/21 Carolyn Mains 12/31/21

Omega Funds VII Oversubscribed at $650 Million

Carolyn Mains 9/21/21 Carolyn Mains 9/21/21

Blue Bear Capital Fund II Oversubscribed at $150 Million

Carolyn Mains 2/22/21 Carolyn Mains 2/22/21

Peterson Partners Fund IX Closes at $225 Million

Carolyn Mains 10/9/20 Carolyn Mains 10/9/20

Sweetwater II Oversubscribed at $350 Million

Jeremy Hopwood 9/21/20 Jeremy Hopwood 9/21/20

Corridor Capital III Closes $118 Million

Corridor Capital, LLC (“Corridor Capital”), a Los Angeles-based private equity firm, announced the final closing of Corridor Capital III (“CC III” or the “Fund”).

Emily Pangilinan 12/11/19 Emily Pangilinan 12/11/19

Omega Funds Closes $438 Million Fund VI Aimed at the Life Sciences

Fifteen-year-old Omega Funds raised $438 million to finance its sixth fund aimed at creating and investing in life sciences companies that target the most urgent medical needs. To date, the investment firm has raised more than $1 billion to invest in drug development companies.

Emily Pangilinan 1/21/19 Emily Pangilinan 1/21/19

Harken Hires Vice President Steve Williamson

Harken Capital Securities LLC (“Harken”), a provider of private equity fund placement and secondary advisory services, announced today that Steve Williamson has joined the firm as Vice President.

Emily Pangilinan 12/14/18 Emily Pangilinan 12/14/18

TVV Capital Raises Fourth Lower Mid-Market Fund

Visit Their Website: http://tvvcapital.com/

Emily Pangilinan 10/9/17 Emily Pangilinan 10/9/17

Harken Capital Hires Marketing Director Carolyn Mains

Harken Capital Securities, LLC (“Harken”), a provider of private equity fund placement and secondary advisory services, announced today that Carolyn Mains has joined the firm as Marketing Director.